date:Jul 26, 2022
venue of approximately $35 million with EBITDA margins in the low double digits prior to synergies. The transaction is expected to be slightly dilutive to 2022 GAAP earnings per share but approximately two cents accretive on an adjusted basis, which excludes transaction-related costs and purchase price accounting. The purchase price was undisclosed.